Expression without boundaries

Cell-free protein synthesis in pharmaceutical research

Marco G. Casteleijn, Arto Urtti, Sanjay Sarkhel

Research output: Contribution to journalArticleScientificpeer-review

34 Citations (Scopus)

Abstract

Proteins are an increasingly important class of new drugs. Pharmaceutical proteins are usually expressed in cell based systems in the development phase and in production, and although cell free methods have recently emerged they have not been used widely for therapeutic protein development or production. Cell free expression methodology is well suited for pharmaceutical protein expression and engineering and will probably become more commonly used in the future. Cell free expression allows protein engineering in high throughput format, flexible strategies for glycosylation and chemical conjugation, and allows easy use of unnatural amino acids as building blocks of proteins. Thus, cell free expression can be used to modify protein solubility, stability, and pharmacokinetics of therapeutic proteins. Likewise, it is potentially useful in protein development for biomaterial matrices, nanoparticles, and vaccines. This review illustrates the potential of cell free expression in pharmaceutical protein research and development while highlighting both advantages and limitations of the method.
Original languageEnglish
Pages (from-to)39-47
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume440
Issue number1
DOIs
Publication statusPublished - 2 Jan 2013
MoE publication typeA1 Journal article-refereed

Fingerprint

Proteins
Protein Engineering
Pharmaceutical Preparations
Protein Stability
Biocompatible Materials
Pharmaceutical Research
Glycosylation
Nanoparticles
Solubility
Vaccines
Pharmacokinetics
Amino Acids
Therapeutics
Research

Keywords

  • Cell free expression
  • High throughput
  • Protein development
  • Protein engineering
  • Protein expression

Cite this

@article{408220949bc84cf3bb49804214e4ee9c,
title = "Expression without boundaries: Cell-free protein synthesis in pharmaceutical research",
abstract = "Proteins are an increasingly important class of new drugs. Pharmaceutical proteins are usually expressed in cell based systems in the development phase and in production, and although cell free methods have recently emerged they have not been used widely for therapeutic protein development or production. Cell free expression methodology is well suited for pharmaceutical protein expression and engineering and will probably become more commonly used in the future. Cell free expression allows protein engineering in high throughput format, flexible strategies for glycosylation and chemical conjugation, and allows easy use of unnatural amino acids as building blocks of proteins. Thus, cell free expression can be used to modify protein solubility, stability, and pharmacokinetics of therapeutic proteins. Likewise, it is potentially useful in protein development for biomaterial matrices, nanoparticles, and vaccines. This review illustrates the potential of cell free expression in pharmaceutical protein research and development while highlighting both advantages and limitations of the method.",
keywords = "Cell free expression, High throughput, Protein development, Protein engineering, Protein expression",
author = "Casteleijn, {Marco G.} and Arto Urtti and Sanjay Sarkhel",
year = "2013",
month = "1",
day = "2",
doi = "10.1016/j.ijpharm.2012.04.005",
language = "English",
volume = "440",
pages = "39--47",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

Expression without boundaries : Cell-free protein synthesis in pharmaceutical research. / Casteleijn, Marco G.; Urtti, Arto; Sarkhel, Sanjay.

In: International Journal of Pharmaceutics, Vol. 440, No. 1, 02.01.2013, p. 39-47.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Expression without boundaries

T2 - Cell-free protein synthesis in pharmaceutical research

AU - Casteleijn, Marco G.

AU - Urtti, Arto

AU - Sarkhel, Sanjay

PY - 2013/1/2

Y1 - 2013/1/2

N2 - Proteins are an increasingly important class of new drugs. Pharmaceutical proteins are usually expressed in cell based systems in the development phase and in production, and although cell free methods have recently emerged they have not been used widely for therapeutic protein development or production. Cell free expression methodology is well suited for pharmaceutical protein expression and engineering and will probably become more commonly used in the future. Cell free expression allows protein engineering in high throughput format, flexible strategies for glycosylation and chemical conjugation, and allows easy use of unnatural amino acids as building blocks of proteins. Thus, cell free expression can be used to modify protein solubility, stability, and pharmacokinetics of therapeutic proteins. Likewise, it is potentially useful in protein development for biomaterial matrices, nanoparticles, and vaccines. This review illustrates the potential of cell free expression in pharmaceutical protein research and development while highlighting both advantages and limitations of the method.

AB - Proteins are an increasingly important class of new drugs. Pharmaceutical proteins are usually expressed in cell based systems in the development phase and in production, and although cell free methods have recently emerged they have not been used widely for therapeutic protein development or production. Cell free expression methodology is well suited for pharmaceutical protein expression and engineering and will probably become more commonly used in the future. Cell free expression allows protein engineering in high throughput format, flexible strategies for glycosylation and chemical conjugation, and allows easy use of unnatural amino acids as building blocks of proteins. Thus, cell free expression can be used to modify protein solubility, stability, and pharmacokinetics of therapeutic proteins. Likewise, it is potentially useful in protein development for biomaterial matrices, nanoparticles, and vaccines. This review illustrates the potential of cell free expression in pharmaceutical protein research and development while highlighting both advantages and limitations of the method.

KW - Cell free expression

KW - High throughput

KW - Protein development

KW - Protein engineering

KW - Protein expression

UR - http://www.scopus.com/inward/record.url?scp=84871614444&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2012.04.005

DO - 10.1016/j.ijpharm.2012.04.005

M3 - Article

VL - 440

SP - 39

EP - 47

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -